![Bengt Bergstrom](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bengt Bergstrom
Profile
Bengt Bergstrom worked as a Vice President of Clinical Development at Array BioPharma, Inc. before obtaining a doctorate degree from the University of Lund.
Former positions of Bengt Bergstrom
Companies | Position | End |
---|---|---|
ARRAY TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Training of Bengt Bergstrom
University of Lund | Doctorate Degree |
Experiences
Positions held
Linked companies
Private companies | 1 |
---|---|
Array BioPharma, Inc.
![]() Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
- Stock Market
- Insiders
- Bengt Bergstrom